Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
931.45
-4.30 (-0.46%)
At close: Dec 5, 2025
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.77M INR
Profits / Employee
1.76M INR
Market Cap
937.26B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Aurobindo Pharma | 27,707 |
| Alkem Laboratories | 18,785 |
| Fortis Healthcare | 12,237 |
Zydus Lifesciences News
- 2 days ago - Zydus Lifesciences receives EIR from USFDA for the injectable facility at Jarod - Business Upturn
- 8 days ago - Top stocks to watch today, November 28: Adani Enterprises, Wipro, TCS, Tata Technologies, Zydus Lifesciences and more - Business Upturn
- 8 days ago - Zydus Lifesciences gets USFDA Tentative nod for Empagliflozin and Linagliptin tablets - Business Upturn
- 10 days ago - Zydus Lifesciences signs exclusive licensing agreement with RK Pharma for novel oncology supportive care injectable - Business Upturn
- 10 days ago - Top stocks to watch today, November 26: NCC, Zydus Lifesciences, UBL, Waaree Energies, NELCO and more - Business Upturn
- 10 days ago - Top stocks to watch on November 26, 2025: NCC, Zen Technologies, Zydus Lifesciences, Bharti Airtel, HCL Tech, ACS Technologies in focus today - Business Upturn
- 21 days ago - Zydus Lifesciences secures USFDA approval for Leuprolide Acetate Injection - Business Upturn
- 22 days ago - Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate capsule, 231 mg - Business Upturn